Nemolizumab In Subjects With Prurigo Nodularis
Posted Date: Jan 3, 2022
- Investigator: Alan Fleischer
- Specialties:
- Type of Study: Drug
This is a continuation of a randomized control trial of nemolizumab, an inti-itch drug
Criteria:
Prior Participation In Clinical Trial
Keywords:
Itch, Open Label Extension
For More Information:
Lyssa Casale
513- 558-5650
casale@ucmail.uc.edu